A DuPont de Nemours Inc.-owned research venture is partnering with British startup BioMe Oxford Ltd. in the early stages of developing an orally delivered capsule that can sample gut health to assess the impact of probiotics and other ingredients that effect the microbiome.
The platform technology, BioCapture, has potential to impact both research and healthcare applications through improved sampling of gastrointestinal biomarkers, says...